{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:07:07Z","timestamp":1791378427313,"version":"4.3.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018708","name":"Euratom Research and Training Programme","doi-asserted-by":"publisher","award":["755523"],"award-info":[{"award-number":["755523"]}],"id":[{"id":"10.13039\/100018708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejca.2025.116055","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:43:39Z","timestamp":1761403419000},"page":"116055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study"],"prefix":"10.1016","volume":"231","author":[{"given":"D.S.","family":"Spoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Boekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.E.V.","family":"Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mayinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Borm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vliegenthart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sikkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.A.B.","family":"van den Bogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Sijtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Maduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.G.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.116055_bib1","doi-asserted-by":"crossref","unstructured":"E. Rosenblatt et al., Radiotherapy capacity in European countries: An analysis of the Directory of Radiotherapy Centres (DIRAC) database, Feb. 2013. doi: 10.1016\/S1470-2045(12)70556-9.","DOI":"10.1016\/S1470-2045(12)70556-9"},{"key":"10.1016\/j.ejca.2025.116055_bib2","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCCTCG), Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials, 2011, doi: 10.1016\/S0140.","DOI":"10.1108\/cgij.2012.24817baa.014"},{"issue":"1","key":"10.1016\/j.ejca.2025.116055_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2016.02.016","article-title":"How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis","volume":"119","author":"Borras","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.116055_bib5","article-title":"Expanding global access to radiotherapy","author":"Atun","year":"2015","journal-title":"Lancet Publ Group"},{"issue":"4","key":"10.1016\/j.ejca.2025.116055_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","article-title":"Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003\u20132013","volume":"93","author":"Taylor","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ejca.2025.116055_bib7","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/j.clon.2024.05.002","article-title":"Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015\u20132023","volume":"36","author":"Holt","year":"2024","journal-title":"Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2025.116055_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2025.116055_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116055_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.radonc.2020.02.007","article-title":"Prognosis of acute coronary syndromes after radiotherapy for breast cancer","volume":"146","author":"Boekel","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.116055_bib11","doi-asserted-by":"crossref","unstructured":"Dec. 2010. doi: 10.1667\/RR1862.1.","DOI":"10.1667\/RR1862.1"},{"issue":"4","key":"10.1016\/j.ejca.2025.116055_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","article-title":"Model-based selection for proton therapy in breast cancer: development of the national indication protocol for proton therapy and first clinical experiences","volume":"34","author":"Boersma","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116055_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2021.07.025","article-title":"Validation of separate multi-atlases for auto segmentation of cardiac substructures in CT-scans acquired in deep inspiration breath hold and free breathing","volume":"163","author":"Spoor","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.116055_bib14","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.71.4113","article-title":"Radiation-induced heart disease after breast cancer treatment: How big a problem, and how much can - And should - We try to reduce it?, Apr. 10","author":"Recht","year":"2017","journal-title":"Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116055_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-017-4398-y","article-title":"Radiation-related heart disease after breast cancer radiation therapy in Korean women","volume":"166","author":"Chang","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ejca.2025.116055_bib16","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2021.03.004","article-title":"The importance of radiation dose to the atherosclerotic plaque in the left anterior descending coronary artery for radiation-induced cardiac toxicity of breast cancer patients?","volume":"110","author":"van den Bogaard","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejca.2025.116055_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcmg.2015.02.006","article-title":"Coronary artery calcium scanning past, present, and future","volume":"8","author":"Hecht","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ejca.2025.116055_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-022-01073-z","article-title":"Evolution of coronary calcium screening for assessment of atherosclerotic cardiovascular disease risk and role in preventive cardiology","author":"Wong","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.ejca.2025.116055_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ejhf.1620","article-title":"Heart failure after treatment for breast cancer","volume":"22","author":"Boekel","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ejca.2025.116055_bib20","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2025.116055_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2025.116055_bib22","unstructured":"World Health Organisation, International Classification of Diseases 11th Revision.\u201d Accessed: Mar. 28, 2022. [Online]. Available: \u3008https:\/\/icd.who.int\/en\u3009."},{"key":"10.1016\/j.ejca.2025.116055_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2019.03.013","article-title":"Development and evaluation of an auto-segmentation tool for the left anterior descending coronary artery of breast cancer patients based on anatomical landmarks","volume":"136","author":"van den Bogaard","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.116055_bib24","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ejca.2025.116055_bib25","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/sim.9275","article-title":"Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome","volume":"41","author":"Riley","year":"2022","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2025.116055_bib26","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"2004"},{"key":"10.1016\/j.ejca.2025.116055_bib27","unstructured":"R Core Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.\u201d Accessed: Aug. 19, 2022. [Online]. Available: \u3008http:\/\/www.r-project.org\/index.html\u3009."},{"key":"10.1016\/j.ejca.2025.116055_bib28","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","author":"Malakar","year":"2019","journal-title":"WileyLiss Inc"},{"key":"10.1016\/j.ejca.2025.116055_bib29","doi-asserted-by":"crossref","unstructured":"P.W.F. Wilson, R.B. D\u2019agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel, Prediction of Coronary Heart Disease Using Risk Factor Categories, 1998. [Online]. Available: \u3008http:\/\/www.nhlbi.nih.gov\/nhlbi\/fram\/\u3009.","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"10.1016\/j.ejca.2025.116055_bib30","article-title":"Cardiovascular toxicity of breast cancer treatment: an update","author":"Papageorgiou","year":"2021","journal-title":"Springe Sci Bus Media Dtschl GmbH"},{"issue":"7","key":"10.1016\/j.ejca.2025.116055_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamaoncol.2021.1144","article-title":"Identification of risk of cardiovascular disease by automatic quantification of coronary artery calcifications on radiotherapy planning CT scans in patients with breast cancer","volume":"7","author":"Gal","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116055_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.radonc.2017.10.009","article-title":"Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?","volume":"126","author":"Roos","year":"2018","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2025.116055_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167925","article-title":"Automatic coronary artery calcium scoring on radiotherapy planning CT Scans of breast cancer patients: Reproducibility and association with traditional cardiovascular risk factors","volume":"11","author":"Gernaat","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.ejca.2025.116055_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110705","article-title":"The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort","volume":"204","author":"Refsgaard","year":"2025","journal-title":"Radiother Oncol"},{"issue":"10416","key":"10.1016\/j.ejca.2025.116055_bib35","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(23)01082-6","article-title":"Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials","volume":"402","author":"Taylor","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejca.2025.116055_bib36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/djab113","article-title":"Side effects 15 years after lymph node irradiation in breast cancer: randomized EORTC Trial 22922\/10925","volume":"113","author":"Poortmans","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2025.116055_bib37","article-title":"Is the risk of ischemic heart disease in women after radiotherapy for breast cancer nowadays still (linearly) associated with the mean heart dose?","author":"Struikmans","year":"2024","journal-title":"Med J Swed AB"},{"issue":"5","key":"10.1016\/j.ejca.2025.116055_bib38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2021.03.004","article-title":"The importance of radiation dose to the atherosclerotic plaque in the left anterior descending coronary artery for radiation-induced cardiac toxicity of breast cancer patients?","volume":"110","author":"van den Bogaard","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ejca.2025.116055_bib39","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.9906","article-title":"Early detection of cardiovascular changes after radiotherapy for breast cancer: protocol for a European multicenter prospective cohort study (MEDIRAD EARLY HEART Study)","volume":"7","author":"Walker","year":"2018","journal-title":"JMIR Res Protoc"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925009414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925009414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:54:16Z","timestamp":1773809656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925009414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"alternative-id":["S0959804925009414"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116055","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116055"}}